Cargando…
A luminescence-based assay for monitoring changes in alpha-synuclein aggregation in living cells
Parkinson's disease is characterized by the accumulation of protein aggregates in the brain, termed Lewy bodies. Lewy bodies are predominantly composed of α-synuclein and mutations that increase the aggregation potential of α-synuclein have been associated with early on-set disease. Assays capa...
Autores principales: | Nelson, Travis J., Truong, Tiffany, Truong, BaoLong, Bilyeu, Camden V., Zhao, Jia, Stains, Cliff I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266166/ https://www.ncbi.nlm.nih.gov/pubmed/32489651 http://dx.doi.org/10.1039/d0ra02720k |
Ejemplares similares
-
A Luminescence-Based System for Identification of
Genetically Encodable Inhibitors of Protein Aggregation
por: Nelson, Travis J., et al.
Publicado: (2020) -
SUMOylation of Alpha-Synuclein Influences on Alpha-Synuclein Aggregation Induced by Methamphetamine
por: Zhu, Lin-nan, et al.
Publicado: (2018) -
Alpha-Synuclein Aggregation in Parkinson's Disease
por: Srinivasan, E., et al.
Publicado: (2021) -
Alpha-Synuclein FRET Biosensors Reveal Early Alpha-Synuclein Aggregation in the Endoplasmic Reticulum
por: Miraglia, Fabiana, et al.
Publicado: (2020) -
Monitoring α-synuclein aggregation
por: Estaun-Panzano, Juan, et al.
Publicado: (2023)